天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 372-20-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 372-20-3
Chemical Structure| 372-20-3
Structure of 372-20-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 372-20-3 ]

Related Doc. of [ 372-20-3 ]

Alternatived Products of [ 372-20-3 ]
Product Citations

Product Citations

Canale, Vittorio ; Czekajewska, Joanna ; Klesiewicz, Karolina , et al. DOI: PubMed ID:

Abstract: The alarming increase in the resistance of bacteria to the currently available antibiotics necessitates the development of new effective antimicrobial agents that are active against bacterial pathogens causing major public health problems. For this purpose, our inhouse libraries were screened against a wide panel of clin. relevant Gram-pos. and Gram-neg. bacteria, based on which compound I was selected for further optimization. Synthetic efforts in a group of arylurea derivatives of aryloxy(1-phenylpropyl) alicyclic diamines, followed with an in vitro evaluation of the activity against multidrug-resistant strains identified compound 44 (1-(3-chlorophenyl)-3-(1-{3-phenyl-3-[3-(trifluoromethyl)phenoxy] propyl}piperidin-4-yl)urea). Compound 44 showed antibacterial activity against Gram-pos. bacteria including fatal drug-resistant strains i.e., Staphylococcus aureus (methicillin-resistant, MRSA; vancomycin-intermediate, VISA) and Enterococcus faecium (vancomycin-resistant, VREfm) at low concentrations (0.78-3.125 μg/mL) comparable to last resort antibiotics (i.e., vancomycin and linezolid). It is also potent against biofilm-forming S. aureus and Staphylococcus epidermidis (including linezolid-resistant, LRSE) strains, but with no activity against Gram-neg. bacteria (Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa). Compound 44 showed strong bactericidal properties against susceptible and drug-resistant Gram-pos. bacteria. Depolarization of the bacterial cytoplasmic membrane induced by compound 44 suggests a dissipation of the bacterial membrane potential as its mechanism of antibacterial action. The high antimicrobial activity of compound 44, along with its selectivity over mammalian cells (lung MCR-5 and skin BJ fibroblast cell lines) and no hemolytic properties toward horse erythrocytes, proposes arylurea derivatives of aryloxy(1-phenylpropyl) alicyclic diamines for development of novel antibacterial agents.

Keywords: Arylurea derivatives ; Antibacterial properties ; Anti-MRSA activity ; Anti-VRE activity ; Anti-LRSE activity ; Depolarization of bacterial cell membrane

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Product Details of [ 372-20-3 ]

CAS No. :372-20-3 MDL No. :MFCD00002254
Formula : C6H5FO Boiling Point : -
Linear Structure Formula :- InChI Key :SJTBRFHBXDZMPS-UHFFFAOYSA-N
M.W : 112.10 Pubchem ID :9743
Synonyms :

Calculated chemistry of [ 372-20-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 28.42
TPSA : 20.23 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.61 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.37
Log Po/w (XLOGP3) : 1.93
Log Po/w (WLOGP) : 1.95
Log Po/w (MLOGP) : 1.9
Log Po/w (SILICOS-IT) : 1.84
Consensus Log Po/w : 1.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.31
Solubility : 0.554 mg/ml ; 0.00494 mol/l
Class : Soluble
Log S (Ali) : -1.98
Solubility : 1.18 mg/ml ; 0.0105 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.04
Solubility : 1.02 mg/ml ; 0.0091 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 372-20-3 ]

Signal Word:Danger Class:8,6.1
Precautionary Statements:P280-P301+P310-P305+P351+P338 UN#:2922
Hazard Statements:H227-H301+H311+H331-H314-H412 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 372-20-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 372-20-3 ]
  • Downstream synthetic route of [ 372-20-3 ]

[ 372-20-3 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 372-20-3 ]
  • [ 79-11-8 ]
  • [ 404-98-8 ]
Reference: [1] Journal of the American Chemical Society, 1943, vol. 65, p. 1555
[2] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 14, p. 4336 - 4347
[3] Journal of Heterocyclic Chemistry, 2016, vol. 53, # 1, p. 183 - 187
  • 2
  • [ 372-20-3 ]
  • [ 105-36-2 ]
  • [ 404-98-8 ]
Reference: [1] Patent: WO2014/100730, 2014, A1, . Location in patent: Paragraph 00262
[2] Patent: US2019/83482, 2019, A1, . Location in patent: Paragraph 0236-0237
  • 3
  • [ 372-20-3 ]
  • [ 96-32-2 ]
  • [ 404-98-8 ]
Reference: [1] Tetrahedron Letters, 2015, vol. 56, # 29, p. 4383 - 4387
  • 4
  • [ 372-20-3 ]
  • [ 404-98-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2006, vol. 127, # 2, p. 291 - 295
[2] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 1, p. 173 - 179
[3] Bulletin of the Korean Chemical Society, 2015, vol. 36, # 10, p. 2549 - 2552
  • 5
  • [ 372-20-3 ]
  • [ 107-30-2 ]
  • [ 126940-10-1 ]
YieldReaction ConditionsOperation in experiment
91%
Stage #1: With N-ethyl-N,N-diisopropylamine In dichloromethane at -10℃; for 0.25 h;
Stage #2: at -10 - 20℃; for 22.08 h;
A solution of 100 gm (0.892 mol) 3-fluorophenol in 800 ML dichloromethane was cooled to -10°C.
To this solution were added 155 gm (1.20 mol) diisopropylethylamine dropwise over 15 minutes..
Residual diisopropylethylamine in the addition funnel was rinsed into the reaction mixture with 100 ML dichloromethane..
To the resulting solution were added 100 gm (1.24 mol) chloromethyl methyl ether over 5 minutes, resulting an exotherm from -10°C to 2°C.
The reaction mixture was allowed to warm to room temperature..
After 22 hours the reaction mixture was quenched with 500 ML water..
The organic phase was washed with 500 ML 2M aqueous sodium bisulfate followed by 300 ML 1M sodium hydroxide..
The remaining organics were dried over magnesium sulfate and concentrated under reduced pressure to provide 130 gm of a yellow oil..
The oil was distilled (kugelrohr, 80°C, 0.1 torr) to provide 126 gm (91percent) of the desired compound as a colorless oil.
Reference: [1] ChemBioChem, 2015, vol. 16, # 17, p. 2445 - 2450
[2] Patent: EP1204660, 2004, B1, . Location in patent: Page 19
[3] European Journal of Organic Chemistry, 2001, # 15, p. 2911 - 2915
[4] Tetrahedron Letters, 2001, vol. 42, # 37, p. 6499 - 6502
[5] ChemMedChem, 2017, vol. 12, # 1, p. 23 - 27
  • 6
  • [ 109-87-5 ]
  • [ 372-20-3 ]
  • [ 126940-10-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1989, vol. 26, p. 1293 - 1298
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 372-20-3 ]

Fluorinated Building Blocks

Chemical Structure| 371-41-5

[ 371-41-5 ]

4-Fluorophenol

Similarity: 0.97

Chemical Structure| 75996-29-1

[ 75996-29-1 ]

5-Fluorobenzene-1,3-diol

Similarity: 0.94

Chemical Structure| 2713-34-0

[ 2713-34-0 ]

3,5-Difluorophenol

Similarity: 0.94

Chemical Structure| 2713-31-7

[ 2713-31-7 ]

2,5-Difluorophenol

Similarity: 0.91

Chemical Structure| 55660-73-6

[ 55660-73-6 ]

2-Fluorobenzene-1,4-diol

Similarity: 0.91

Aryls

Chemical Structure| 371-41-5

[ 371-41-5 ]

4-Fluorophenol

Similarity: 0.97

Chemical Structure| 75996-29-1

[ 75996-29-1 ]

5-Fluorobenzene-1,3-diol

Similarity: 0.94

Chemical Structure| 2713-34-0

[ 2713-34-0 ]

3,5-Difluorophenol

Similarity: 0.94

Chemical Structure| 2713-31-7

[ 2713-31-7 ]

2,5-Difluorophenol

Similarity: 0.91

Chemical Structure| 55660-73-6

[ 55660-73-6 ]

2-Fluorobenzene-1,4-diol

Similarity: 0.91

; ;